Lv3
390 积分 2023-07-16 加入
406P Neoadjuvant chemo-immunotherapy versus neoadjuvant chemoradiotherapy for locally advanced esophageal squamous cell carcinoma
21天前
已完结
Oncolytic virotherapy: basic principles, recent advances and future directions
26天前
已完结
Oncolytic Viruses as Cancer Therapeutics: From Mechanistic Insights to Clinical Translation
27天前
已完结
Oncolytic Viruses as Cancer Therapeutics: From Mechanistic Insights to Clinical Translation
28天前
已完结
Different survival and recurrence patterns between neoadjuvant radiochemotherapy and immunochemotherapy in esophageal squamous cell carcinoma
1个月前
已完结
Patterns of recurrence after esophagectomy following neoadjuvant Immunochemotherapy in patients with thoracic esophageal squamous cell carcinoma
1个月前
已完结
186. RECURRENT DISEASE AFTER ESOPHAGEAL CANCER SURGERY; A SUBSTUDY OF THE DUTCH NATIONWIDE IVORY STUDY
1个月前
已完结
Oxidative Stress-Related lncRNAs Are Potential Biomarkers for Predicting Prognosis and Immune Responses in Patients With LUAD
3个月前
已完结
Identification of Hub Prognosis-Associated Oxidative Stress Genes in Pancreatic Cancer Using Integrated Bioinformatics Analysis
3个月前
已完结
Mendelian randomization for nephrologists
4个月前
已完结
皖公网安备34019202002308
